These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 26979081)

  • 1. Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy.
    Suwala AK; Hanaford A; Kahlert UD; Maciaczyk J
    J Neuropathol Exp Neurol; 2016 May; 75(5):388-96. PubMed ID: 26979081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteins of the Wnt signaling pathway as targets for the regulation of CD133+ cancer stem cells in glioblastoma.
    Shevchenko V; Arnotskaya N; Korneyko M; Zaytsev S; Khotimchenko Y; Sharma H; Bryukhovetskiy I
    Oncol Rep; 2019 May; 41(5):3080-3088. PubMed ID: 30864699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt inhibition is dysregulated in gliomas and its re-establishment inhibits proliferation and tumor sphere formation.
    Kierulf-Vieira KS; Sandberg CJ; Grieg Z; Günther CC; Langmoen IA; Vik-Mo EO
    Exp Cell Res; 2016 Jan; 340(1):53-61. PubMed ID: 26712519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells.
    De Robertis A; Valensin S; Rossi M; Tunici P; Verani M; De Rosa A; Giordano C; Varrone M; Nencini A; Pratelli C; Benicchi T; Bakker A; Hill J; Sangthongpitag K; Pendharkar V; Liu B; Ng FM; Then SW; Jing Tai S; Cheong SM; He X; Caricasole A; Salerno M
    Mol Cancer Ther; 2013 Jul; 12(7):1180-9. PubMed ID: 23619303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
    Kaur N; Chettiar S; Rathod S; Rath P; Muzumdar D; Shaikh ML; Shiras A
    Mol Cell Neurosci; 2013 May; 54():44-57. PubMed ID: 23337036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the Wnt Pathway to Defining Biology of Glioblastoma.
    Tompa M; Kalovits F; Nagy A; Kalman B
    Neuromolecular Med; 2018 Dec; 20(4):437-451. PubMed ID: 30259273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
    Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
    Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.
    Auffinger B; Spencer D; Pytel P; Ahmed AU; Lesniak MS
    Expert Rev Neurother; 2015; 15(7):741-52. PubMed ID: 26027432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma.
    Shevchenko V; Arnotskaya N; Zaitsev S; Sharma A; Sharma HS; Bryukhovetskiy A; Pak O; Khotimchenko Y; Bryukhovetskiy I
    Int Rev Neurobiol; 2020; 151():185-200. PubMed ID: 32448607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway.
    Adamo A; Fiore D; De Martino F; Roscigno G; Affinito A; Donnarumma E; Puoti I; Ricci Vitiani L; Pallini R; Quintavalle C; Condorelli G
    Oncotarget; 2017 Feb; 8(8):13476-13487. PubMed ID: 28086236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
    Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
    Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rethinking Glioblastoma Therapy: MDA-9/Syntenin Targeted Small Molecule.
    Das SK; Sarkar D; Cavenee WK; Emdad L; Fisher PB
    ACS Chem Neurosci; 2019 Mar; 10(3):1121-1123. PubMed ID: 30681320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity.
    Balça-Silva J; do Carmo A; Tão H; Rebelo O; Barbosa M; Moura-Neto V; Sarmento-Ribeiro AB; Lopes MC; Moreira JN
    Exp Cell Res; 2018 Sep; 370(1):68-77. PubMed ID: 29902537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.
    Cilibrasi C; Riva G; Romano G; Cadamuro M; Bazzoni R; Butta V; Paoletta L; Dalprà L; Strazzabosco M; Lavitrano M; Giovannoni R; Bentivegna A
    PLoS One; 2017; 12(1):e0169854. PubMed ID: 28081224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNT signaling in glioblastoma and therapeutic opportunities.
    Lee Y; Lee JK; Ahn SH; Lee J; Nam DH
    Lab Invest; 2016 Feb; 96(2):137-50. PubMed ID: 26641068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt pathway markers in molecular subgroups of glioblastoma.
    Tompa M; Nagy A; Komoly S; Kalman B
    Brain Res; 2019 Sep; 1718():114-125. PubMed ID: 31075260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhodiola crenulata inhibits Wnt/β-catenin signaling in glioblastoma.
    Mora MC; Bassa LM; Wong KE; Tirabassi MV; Arenas RB; Schneider SS
    J Surg Res; 2015 Aug; 197(2):247-55. PubMed ID: 25998182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New glioma therapy using specific microRNAs].
    Halle B; Andersen C; Schulz MK; Kristensen BW
    Ugeskr Laeger; 2012 Mar; 174(10):630-3. PubMed ID: 22395010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeutics.
    Katsetos CD; Draber P; Kavallaris M
    Anticancer Agents Med Chem; 2011 Oct; 11(8):719-28. PubMed ID: 21707498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma chemotherapeutic agents used in the clinical setting and in clinical trials: Nanomedicine approaches to improve their efficacy.
    Aparicio-Blanco J; Sanz-Arriazu L; Lorenzoni R; Blanco-Prieto MJ
    Int J Pharm; 2020 May; 581():119283. PubMed ID: 32240807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.